Caribou Biosciences, Inc. (CRBU) stock
CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3074% below fair value
$0.33−0.01 (-4.29%)
Close on Nov 18, 2026Market cap $34.96MP/E –Yield –
Caribou Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Caribou Biosciences's market cap was $41.41M on Nov 11, 2026, against $181.33M a year earlier. Over the last 5 years it ranged from $41.41M to $905.72M, with a median of $239.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $41.41M | -72.1% |
| 2025 | Dec 31, 2025 | $148.61M | +3.2% |
| 2024 | Dec 31, 2024 | $143.98M | -71.6% |
| 2023 | Dec 29, 2023 | $506.71M | +32.3% |
| 2022 | Dec 30, 2022 | $383.00M | -57.7% |
| 2021 | Dec 31, 2021 | $905.72M | – |
See a number that looks wrong?